Showing results (1861-1870 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|May 24, 2018
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderTobias Banaschewski, Mats Johnson, Peter Nagy, et al.CNS Drugs|September 18, 2016
Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current UnderstandingGin S Malhi, Tim OuthredCNS Drugs|July 3, 2017
Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use DisorderAndrew Naglich, Bryon Adinoff, E Sherwood BrownCNS Drugs|May 30, 2018
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled StudyAyman Tourbah, Olivier Gout, Alain Vighetto, et al.CNS Drugs|June 30, 2017
Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter StudySrihari Gopal, Rosanne Lane, Isaac Nuamah, et al.CNS Drugs|June 2, 2009
Safety of selective serotonin reuptake inhibitors in pregnancySura Alwan, Jan M FriedmanCNS Drugs|May 21, 2009
Complete suppression of craving in alcohol-dependent individuals: is it possible?Falk KieferCNS Drugs|October 9, 2008
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disordersDavid V Sheehan, Matthew S Keene, Michael Eaddy, et al.CNS Drugs|January 29, 2009
Role of antiepileptic drugs in the management of eating disordersSusan L McElroy, Anna I Guerdjikova, Brian Martens, et al.Pageof 211